Safety and efficacy of once-daily dexfadrostat phosphate in patients with primary aldosteronism: a randomised, parallel group, multicentre, phase 2 trial
Article in EClinicalMedicine (April 2024)
The most recent citing publications are shown below. View all 42 publications that cite this research output on Dimensions.
Aldosterone synthase inhibitor (BI 690517) therapy for people with diabetes and albuminuric chronic kidney disease: A multicentre, randomized, double‐blind, placebo‐controlled, Phase I trial
Article in Diabetes Obesity and Metabolism (March 2024)
Design and synthesis of fluorine aromatic scaffolds containing drugs approved by the US FDA from 2002 to 2022
Article in Results in Chemistry (January 2024)